Aclaris Therapeutics, Inc. (ACRS)


Stock Price Forecast

April 19, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Aclaris Therapeutics, Inc. chart...

About the Company

We do not have any company description for Aclaris Therapeutics, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

62

Exchange

Nasdaq

$10M

Total Revenue

62

Employees

$88M

Market Capitalization

-0.87

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ACRS News

Aclaris Therapeutics Inc ACRS

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Favourable Signals For Aclaris Therapeutics: Numerous Insiders Acquired Stock

12d ago, source:

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying ...

Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer

11h ago, source:

Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision ...

Aclaris: Q4 Earnings Snapshot

1mon ago, source: SFGate

WAYNE, Pa. (AP) — WAYNE, Pa. (AP) — Aclaris Therapeutics Inc. (ACRS) on Tuesday reported a loss of $1.5 million in its fourth quarter. The Wayne, Pennsylvania-based company said it had a loss ...

Aclaris Therapeutics Inc ACRS

29d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aclaris Therapeutics Inc.

26d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Aclaris Therapeutics Inc

28d ago, source: U.S. News & World Report

Analysts say investors should buy these undervalued stocks.

Aclaris Therapeutics Inc (ACRS)

4d ago, source: Investing

View the ACRS option chain and compare options of Aclaris Therapeutics Inc stock. Analyze the various options available, including call options (the right to buy) and put options (the right to ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...